02 May 2003
Poly(ADP-ribose) polymerase (PARP) activation is an early event in angiotensin-induced cardiovascular disordersC. Szabo, P. Pacher, K. Komjati, J. Mabley, R. Benko, M. Kollai, M. Kollai
Med Sci Monit 2003; 9(1): 68- :: ID: 15209
Angiotensin II (ANG II) is a well-established participant in many cardiovascular disorders. Recent work demonstrated that infusion of ANG II at sub-pressor doses induces the formation of 3-nitrotyrosine (a stable biomarker of tissue peroxynitrite formation). Here we investigated the role of PARP, a multifunctional nuclear enzyme in the development of AII-induced endothelial dysfunction in the rat. AII infusion to Sprague-Dawley rats (200 ng/kg/min) for 7 days induced the development of endothelial dysfunction, as assessed by the endothelium-dependent relaxant responses to acetylcholine in the thoracic aorta ex vivo. This endothelial dysfunction was sustained when AII was infused at the same rate for an additional 1 week period.The PARP inhibitors PJ34  or INO-1001 (J Am Coll Surg, in press, 2002) at doses of 20 mg/kg/day, starting from Day 1, prevented the development of the endothelial dysfunction. Administration of PJ34 or INO-1001 for the second week only, restored normal endothelial function. Immunohistochemical detection of poly(ADP-ribose) confirmed that the PARP inhibitors blocks vascular PARP activation in the AII-treated animals. PARP activation may play an early role in the pathogenesis of various AII-mediated vascular diseases.References: 1.Virág L, Szabó C: The therapeutic potential of PARP inhibition. Pharmacological Reviews, 2002; 54: 375-429 2.Soriano FG, Virág L, Jagtap P et al: Diabetic endothelial dysfunction: the role of poly (ADP-ribose) polymerase activation. Nature Medicine, 2001; 7: 108-113 3.Pacher P, Mabley JG, Soriano FG et al: Activation of poly(ADP-ribose) polymerase contributes to the endothelial dysfunction associated with hypertension and aging. Int J Mol Med, 2002; 9: 659-664
Keywords: vascular dysfunction, endothelium-dependent relaxation, angiotensin, Nitric Oxide
01 May 2022 : EditorialEditorial: Cardiovascular Complications at One Year After SARS-CoV-2 Infection are Independent of Underlying Cardiovascular Risk Factors or Severity of COVID-19
Med Sci Monit 2022; 28:e937048
04 May 2022 : Clinical ResearchEffects of Wearing Face Masks on Exercise Capacity and Ventilatory Anaerobic Threshold in Healthy Subjects ...
Med Sci Monit In Press; DOI: 10.12659/MSM.936069
27 May 2022 : Clinical ResearchFactors Associated with Falls During Hospitalization for Coronavirus Disease 2019 (COVID-19)
Med Sci Monit 2022; 28:e936547
25 May 2022 : Review articleNarrative Review of the Mechanism of Hip Prosthesis Dislocation and Methods to Reduce the Risk of Dislocation
Med Sci Monit In Press; DOI: 10.12659/MSM.935665
24 May 2022 : Clinical ResearchRemimazolam Tosilate Sedation with Adjuvant Sufentanil in Chinese Patients with Liver Cirrhosis Undergoing ...
Med Sci Monit In Press; DOI: 10.12659/MSM.936580
Most Viewed Current Articles
30 Dec 2021 : Clinical ResearchRetrospective Study of Outcomes and Hospitalization Rates of Patients in Italy with a Confirmed Diagnosis o...
Med Sci Monit 2021; 27:e935379
08 Mar 2022 : Review articleA Review of the Potential Roles of Antioxidant and Anti-Inflammatory Pharmacological Approaches for the Man...
Med Sci Monit 2022; 28:e936292
01 Nov 2020 : Review articleLong-Term Respiratory and Neurological Sequelae of COVID-19
Med Sci Monit 2020; 26:e928996